Background: Previously, a depth of anesthesia bispectral index (BIS™) <45 was considered lowand found to have no clinical benefit. A BIS <35 was considered very low and was not only without evident clinical benefit but also associated with a greater risk of postoperative delirium. We considered the association between BIS and the anesthetic dose of inhalational agents, quantified using the minimum alveolar concentration (MAC) fraction, which was the patient's end-tidal inhalational agent concentration divided by the agent's altitude- and age-adjusted minimum alveolar percentage concentration. The MAC fraction was displayed on the anesthesia machine. When the MAC fraction >1.0 and the BIS <35, it implies that the inhalational anesthetic agent concentration can be reduced without harmful clinical effects. We hypothesized a substantive percentage of cases (>10%) have long (≥15 minutes) periods having the combination of MAC fraction >1.0 and BIS <35.
Methods: The retrospective database cohort study included N = 8,566 cases from September 13, 2016, to August 12, 2024 that met the following criteria: (1) ≥100 minutes of BIS monitoring (BIS minutes); (2) use of general anesthesia; (3) tracheal intubation and extubation performed in the operating room where the anesthetic was administered; and (4) absence of prone positioning. The latter three were characteristics of studies examining prolonged extubation, defined as ≥15 minutes from the end of surgery. From the = 8,566 cases studied, 1,862,022 BIS minutes were automatically recorded in the electronic health record. Comparisons were made with the matching MAC fractions. A Clopper-Pearson two-sided exact 95% confidence interval was calculated for the planned primary endpoint, the percentage of cases with ≥15 minutes wherein simultaneously the BIS <35 and MAC fraction >1.0. Post hoc, we added a 97.5% confidence interval for the incidence with ≥30 minutes to compare with 10%.
Results: Among the 8,566 cases with ≥100 minutes of BIS monitor use, 29.5% (2,527) had prolonged extubation. There were contemporaneously 152,443 other cases without BIS monitoring. Those other cases had a nearly identical incidence of prolonged extubations (29.3%, 44,675). A total of 375 distinct anesthesia practitioners used the BIS monitor during the 8,566 cases, with each contributing, on average, only 0.27% (standard deviation [SD] = 0.33%) of anesthetic minutes. Among the = 7,031 cases with BIS measured when the MAC fraction ≥0.6, 25% (1,780/7,031) had ≥15 minutes of very low BIS and MAC fraction >1.0. The 95% confidence interval was 24% to 26%. Being considerably larger than 10% ( < 0.0001), post hoc, we repeated the calculations using the threshold of ≥30 minutes of very low BIS and MAC fraction >1.0. The estimated incidence was 15%, with a 97.5% confidence interval of 14% to 16%, also significantly exceeding 10% ( < 0.0001).
Conclusions: If department practices are such that processed electroencephalographic monitoring (e.g., BIS) is commonly used during general anesthesia to assess anesthetic depth, our results recommend auditing the volatile agent concentration and the corresponding anesthetic depth index, as we did in this study. We recommend that feedback and education regarding suitable titration of anesthetic agent concentrations relative to the index should be provided at the departmental level.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694772 | PMC |
http://dx.doi.org/10.7759/cureus.75036 | DOI Listing |
CNS Drugs
January 2025
Department of Cardiology, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Background: Early neurological deterioration (END) is associated with a poor prognosis in acute ischemic stroke (AIS). Effectively lowering low-density lipoprotein cholesterol (LDL-C) can improve the stability of atherosclerotic plaque and reduce post-stroke inflammation, which may be an effective means to lower the incidence of END. The objective of this study was to determine the preventive effects of evolocumab on END in patients with non-cardiogenic AIS.
View Article and Find Full Text PDFSci Rep
January 2025
Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Myocyte disarray and fibrosis are underlying pathologies of hypertrophic cardiomyopathy (HCM) caused by genetic mutations. However, the extent of their contributions has not been extensively evaluated. In this study, we investigated the effects of genetic mutations on myofiber function and fibrosis patterns in HCM.
View Article and Find Full Text PDFEur Geriatr Med
January 2025
School of Health Sciences, Fukushima Medical University, Fukushima, Japan.
Purpose: This cross-sectional study aimed to clarify the relationship between dysphagia and social isolation among community-dwelling older people.
Methods: The study participants were 238 community-dwelling older people (168 women; mean age, 74.0 ± 5.
Sci Rep
January 2025
Department of Epidemiology, School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China.
While recent studies have indicated a potential link between incense burning and respiratory diseases, there is a lack of data specifically focused on diabetic patients. To explore the relationship between indoor incense burning and impaired lung function among Chinese individuals with diabetes, a comprehensive cross-sectional study was undertaken, enrolling 431 adults diagnosed with diabetes. Information on incense burning and characteristics was collected using a structured questionnaire.
View Article and Find Full Text PDFSci Rep
January 2025
Chaum Life Center, CHA University School of Medicine, Seoul, 06062, Korea.
No biomarker can effectively screen for early gastric cancer (EGC). Players in the A disintegrin and metalloproteinase (ADAM)-natural killer group 2 member D (NKG2D) receptor axis may have a role for that. As a proof-of-concept pilot study, the expression of ADAM8, ADAM9, ADAM10, ADAM12, ADAM17, and major histocompatibility complex (MHC) class I chain-related sequence A (MICA), a ligand for NKG2D, in gastric cancer was investigated in silico using The Cancer Genome Atlas (TCGA) database.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!